
    
      This project is an international, multicenter, randomized, partially blind clinical study to
      evaluate efficacy and safety of two different doses of VM-1500 in comparison with Efavirenz
      added to standard antiretroviral therapy including two NRTIs in treatment-na√Øve
      HIV-1-infected patients.
    
  